Munich - Delayed Quote EUR
OKYO Pharma Ltd (OK11.MU)
1.2900
+0.1200
+(10.26%)
At close: 8:08:08 AM GMT+2
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-9,490.5370
-9,490.5370
-7,695.2420
-5,468.0650
-1,600.1980
Investing Cash Flow
--
--
-5.9160
-1.6690
-18.1140
Financing Cash Flow
6,208.5080
6,208.5080
9,323.3540
2,153.2700
7,826.9380
End Cash Position
826.8480
826.8480
4,045.3810
2,700.7240
6,889.3290
Capital Expenditure
--
--
-5.9160
-1.6690
-6.9430
Issuance of Capital Stock
6,208.5080
6,208.5080
7,323.3540
--
230.0190
Issuance of Debt
--
--
2,000
--
7,593.3800
Repayment of Debt
--
--
--
--
-12.3310
Free Cash Flow
-9,490.5370
-9,490.5370
-7,701.1580
-5,469.7340
-1,607.1410
3/31/2021 - 7/1/2022
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ADAG Adagene Inc.
1.3900
-2.80%
PEPG PepGen Inc.
1.6800
+4.35%
NGNE Neurogene Inc.
15.37
-0.45%
REVB Revelation Biosciences, Inc.
2.9300
+3.53%
PRQR ProQR Therapeutics N.V.
1.5400
+6.21%
TSHA Taysha Gene Therapies, Inc.
1.8200
0.00%
BCTX BriaCell Therapeutics Corp.
6.03
+11.05%
EVGN Evogene Ltd.
1.1100
+1.83%
FATE Fate Therapeutics, Inc.
1.3500
+1.50%
PRTG Portage Biotech Inc.
9.27
+3.23%